$1.04
2.97% yesterday
Nasdaq, Dec 03, 10:00 pm CET
ISIN
US19188J3005
Symbol
COCP

Cocrystal Pharma Inc Stock price

$1.04
-0.05 4.59% 1M
-0.64 38.10% 6M
-0.98 48.51% YTD
-0.96 48.00% 1Y
-1.66 61.48% 3Y
-18.64 94.72% 5Y
-249.16 99.58% 10Y
+0.94 940.00% 20Y
Nasdaq, Closing price Wed, Dec 03 2025
+0.03 2.97%
ISIN
US19188J3005
Symbol
COCP
Industry

Key metrics

Basic
Market capitalization
$14.3m
Enterprise Value
$6.6m
Net debt
positive
Cash
$7.7m
Shares outstanding
13.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
1.9
Financial Health
Equity Ratio
70.8%
Return on Equity
-189.0%
ROCE
-109.4%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-9.7m | $-17.5m
EBIT
$-9.8m | $-10.5m
Net Income
$-9.7m | $-11.0m
Free Cash Flow
$-10.0m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
52.0% | 2.2%
EBIT
51.9% | 41.9%
Net Income
48.3% | 39.2%
Free Cash Flow
39.3%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-0.9
FCF per Share
$-0.8
Short interest
1.6%
Employees
11
Rev per Employee
$0.0
Show more

Is Cocrystal Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

Cocrystal Pharma Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Cocrystal Pharma Inc forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Cocrystal Pharma Inc forecast:

Buy
88%
Hold
13%

Financial data from Cocrystal Pharma Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 4.30 4.30
23% 23%
-
- Research and Development Expense 5.47 5.47
63% 63%
-
-9.68 -9.68
52% 52%
-
- Depreciation and Amortization 0.09 0.09
36% 36%
-
EBIT (Operating Income) EBIT -9.77 -9.77
52% 52%
-
Net Profit -9.67 -9.67
48% 48%
-

In millions USD.

Don't miss a Thing! We will send you all news about Cocrystal Pharma Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cocrystal Pharma Inc Stock News

Neutral
GlobeNewsWire
3 days ago
BOTHELL, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a Company overview and clinical progress update at NobleCon 21 – Noble Capital Markets 21st Emerging Growth Equity Conference on Wednesday, December 3, 2025 at 10:00 am Eastern time. The conference is being held at the E...
Neutral
GlobeNewsWire
20 days ago
Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatment Expects to initiate CDI-988 Phase 1b norovirus challenge study in Q1 2026 Granted NIH SBIR award to advance influenza A/B replication inhibitor program BOTHELL, Wash., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the th...
Neutral
GlobeNewsWire
about one month ago
Investment by Directors and Management demonstrates confidence in the Company Potential for an additional $ 1.8 million upon the exercise in full of warrants BOTHELL, Wash., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (the “Company” or “Cocrystal”) announces the completion of a private placement of units priced at-the-market under Nasdaq rules with 743,024 shares of ...
More Cocrystal Pharma Inc News

Company Profile

Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.

Head office United States
CEO Sam Lee
Employees 11
Founded 2008
Website www.cocrystalpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today